FOR Benefit Medicines (FBM) and the Bobby Goldsmith Foundation (BGF) have announced a partnership that will see 100% of profits from the sale of Famciclovir FBM medication go towards funding vital support services for people living with HIV.
FBM's generic medicine, Famciclovir FBM, is now available on prescription for suppression of herpes, and for dispensing through pharmacies nation-wide, at the same cost to patients as their current famciclovir treatment.
"There are over 26,000 people living with HIV in Australia and many of them would use famciclovir at some point as part of their medication adherence," said BGF ceo, Nick Lawson.
FBM was established under a social enterprise model with the sole purpose of distributing 100% of profits to patient support and medical research in Australia.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jun 18
